EUVIMEDEUVIMED entdecken
Crossref

A unified platform for nucleoside analog synthesis

Matthew J Anketell iD, Ethan Fung iD, Wenbin Liu iD, Mahesh Shinde iD, Cyndi Qixin He iD, Kurtis W C Ng iD, Steven M Silverman iD, Louis-Charles Campeau iD, Ralph Pantophlet iD, Robert Britton iD

Science · 14.05.2026 · 392 (6799)

DOI: 10.1126/science.aed6880 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 14.05.2026. Verfasst von Matthew J Anketell und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada. Hauptthemen laut MEDLINE: Nucleosides, Anti-HIV Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Institute of Allergy and Infectious Diseases, Natural Sciences and Engineering Research Council of Canada, Simon Fraser University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nucleoside analogs (NAs) are essential as antiviral and anticancer therapies. Despite decades of focused medicinal chemistry efforts, their related chemical space remains underexplored, mainly owing to their lengthy, single-molecule–oriented syntheses that lack the flexibility required to generate NA libraries. Here we report a flexible, robust, and efficient platform for the high-throughput synthesis of NAs using a photoredox coupling strategy. This approach produces both carbon- and nitrogen-linked NAs and unifies the synthesis of several disparate NA classes, including 4′-thio, 4′-imino, and ProTides, all from a simple, scalable intermediate. Using this platform, we demonstrate the production of a diverse NA library and identify several hit compounds with anti–HIV-1 activity. We expect that this newly developed approach to NAs will inspire and support drug discovery efforts in this area.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleosidesAnti-HIV AgentsHIV-1HumansHigh-Throughput Screening AssaysDrug DiscoveryOxidation-Reduction

Substanzen

NucleosidesAnti-HIV Agents

Autor:innen und Institutionen

  • Department of Chemistry, Simon Fraser University, Burnaby, BC, Canada.
  • Department of Process Research and Development, Merck & Co., Inc., West Point, PA, USA.
  • Modeling and Informatics, Merck & Co., Inc., Rahway, NJ, USA.
  • Faculty of Health Sciences, Simon Fraser University, Burnaby, BC, Canada.
  • Department of Process Research and Development, Merck & Co., Inc., Rahway, NJ, USA.
  • Cloudburst Biotech, Burnaby, BC, Canada.

ORCID-Profile: Matthew J Anketell, Ethan Fung, Wenbin Liu, Mahesh Shinde, Cyndi Qixin He, Kurtis W C Ng, Steven M Silverman, Louis-Charles Campeau, Ralph Pantophlet, Robert Britton

Förderung

  • National Institute of Allergy and Infectious Diseases
  • Natural Sciences and Engineering Research Council of Canada
  • Simon Fraser University
  • Glyconet
  • Merck Sharp & Dohme LLC
  • Consortium de Recherche Biopharmaceutique
  • Cloudburst Biotech

Zitieren

APA

Anketell, M. J., Fung, E., Liu, W., Shinde, M., He, C. Q., Ng, K. W. C., Silverman, S. M., Campeau, L. C., Pantophlet, R., & Britton, R. (2026). A unified platform for nucleoside analog synthesis. Science, 392(6799). https://doi.org/10.1126/science.aed6880

Vancouver

Anketell MJ, Fung E, Liu W, Shinde M, He CQ, Ng KWC, et al. A unified platform for nucleoside analog synthesis. Science. 2026;392(6799). doi:10.1126/science.aed6880

BibTeX
@article{Anketell2026,
  author = {Anketell, Matthew J and Fung, Ethan and Liu, Wenbin and Shinde, Mahesh and He, Cyndi Qixin and Ng, Kurtis W C and Silverman, Steven M and Campeau, Louis-Charles and Pantophlet, Ralph and Britton, Robert},
  title = {A unified platform for nucleoside analog synthesis},
  journal = {Science},
  year = {2026},
  volume = {392},
  number = {6799},
  doi = {10.1126/science.aed6880}
}
Kostenlos starten →